<DOC>
	<DOCNO>NCT00100113</DOCNO>
	<brief_summary>The purpose study assess potential interaction intravenous ( IV ) cocaine 3 dos GBR 12909 .</brief_summary>
	<brief_title>Assessment Potential Interactions Between GBR 12909 Cocaine - 1</brief_title>
	<detailed_description>This Phase 1 , double-blind , placebo-controlled human laboratory clinical pharmacology study assess potential interaction IV cocaine 3 escalate oral dos GBR 12909 . The primary objective determine safety GBR 12909 administration significant interaction GBR 12909 treatment concurrent IV cocaine infusion .</detailed_description>
	<mesh_term>Cocaine-Related Disorders</mesh_term>
	<mesh_term>Cocaine</mesh_term>
	<mesh_term>Vanoxerine</mesh_term>
	<criteria>Must within 20 % ideal body weight must weigh least 45 kg . Must understand study procedure provide write informed consent . Must meet DSM4 criterion nontreatment seek time study . Please contact study site information</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2005</verification_date>
	<keyword>cocaine dependence</keyword>
</DOC>